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ABSTRACT
The Protein Data Bank in Europe-Knowledge Base
(PDBe-KB, https://pdbe-kb.org) is a community-
driven, collaborative resource for literature-derived,
manually curated and computationally predicted
structural and functional annotations of macro-
molecular structure data, contained in the Protein
Data Bank (PDB). The goal of PDBe-KB is two-fold:
(i) to increase the visibility and reduce the fragmen-
tation of annotations contributed by specialist data
resources, and to make these data more findable,
accessible, interoperable and reusable (FAIR) and
(ii) to place macromolecular structure data in their
biological context, thus facilitating their use by the
broader scientific community in fundamental and ap-
plied research. Here, we describe the guidelines of
this collaborative effort, the current status of con-
tributed data, and the PDBe-KB infrastructure, which
includes the data exchange format, the deposition
system for added value annotations, the distributable
database containing the assembled data, and pro-
grammatic access endpoints. We also describe a se-
ries of novel web-pages––the PDBe-KB aggregated
views of structure data––which combine information
on macromolecular structures from many PDB en-
tries. We have recently released the first set of pages
in this series, which provide an overview of available
structural and functional information for a protein of
interest, referenced by a UniProtKB accession.
INTRODUCTION
Since 1971, experimentally determined 3D structures have
been deposited to the Protein Data Bank (PDB)––the single
global archive for macromolecular structures (1). As of Au-
gust 2019, the PDB contains more than 150 000 entries, ref-
erencing over 47 500 unique protein sequences in the Uni-
versal Protein Resource (UniProt) (2), with ∼12 000 new
PDB structures added each year. The continuous improve-
ment of experimental methods drives the expansion of the
protein structural space covered by known structures. Ul-
timately, the goal of structure determination is to gain in-
sights into the function of macromolecules (3), and to ad-
vance this goal, it is essential to place structural data in a
biological context (4).
The wealth of structural data from the PDB is utilised by
hundreds of data resources and scientific software. Many of
these resources add valuable annotations and thereby, en-
hance the biological context of macromolecular structures.
Such annotations include catalytic sites (5), ligand bind-
ing sites (6–8), molecular channels (9), post-translational
modification sites (10,11) and other functional sites (12–
14), context-dependent roles of small molecules (15,16), ef-
fects of genetic variability or mutations (17,18), dynami-
cal properties and flexibility of biopolymer chains (19) and
other biophysical parameters (20,21). Currently, the impact
of these valuable annotations is limited by the following
three factors: (i) the data is fragmented over a large number
of distinct resources, each with its own data structure, for-
mats and access mechanisms, making it difficult to compare
or aggregate even similar types of annotations; (ii) many of
these specialist resources typically reach only a compara-
tively small section of the scientific community; (iii) even
expert users may not be aware of the full extent of the ex-
panding ecosystem of these resources (22).
In an effort to align the management of these valuable
data with the FAIR principles of Findability, Accessibil-
ity, Interoperability and Reusability (23), we have launched
in 2018 the Protein Data Bank in Europe-Knowledge Base
(PDBe-KB, pdbe-kb.org), a community-driven, collabora-
tive resource, whose aim is to place macromolecular struc-
tures in their biological context by bringing together the
various resources providing pieces of this context (Figure
1).
To facilitate this data integration, PDBe-KB partners
have defined a common data exchange schema and for-
mat (available at https://gitlab.ebi.ac.uk/pdbe-kb/funpdbe/
funpdbe-schema) for functional annotations of PDB data.
The schema focuses on the commonalities of the annota-
tions, capturing the minimal required information that can
describe them, and provides links to more comprehensive
views of the data hosted by the contributing partners, allow-
ing users to explore the complete data available at the spe-
cialist data resources. This arrangement ensures that PDBe-
KB remains scalable and maintainable while also increasing
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Figure 1. Traditionally, a PDB entry represents structures based on a single set of experiments, where each structure may represent only a segment of the
full-length protein. However, PDB entries that describe the structure of the same protein are not interconnected. Furthermore, there is a rich ecosystem of
resources and scientific software providing added value annotations based on the structures archived in the PDB, and when combined, these annotations
provide evidence for the biological context of the protein. Therefore, the aim of PDBe-KB is to integrate these annotations and interconnect the various
PDB entries in order to provide comprehensive, aggregated views of biologically meaningful entities, such as full-length proteins.
the visibility of the partner resources, and thus enhancing
the sustainability of the data.
In 2018, PDBe-KB launched a deposition system ac-
cepting annotations from partners, and an infrastructure
to store and expose these data via a distributable database
and an Application Programming Interface (API). Further-
more, in March 2019, PDBe-KB introduced a website for
accessing and displaying the contributed annotations and
PDB data. To date, 18 partner resources from 8 countries
collectively contributed over 520 million manually curated
or predicted residue-level annotations for PDB structures
(Table 1).
PDBe-KB is managed by the Protein Data Bank in Eu-
rope team (PDBe; pdbe.org) (25) at the European Bioin-
formatics Institute. PDBe-KB is also one of the activities
of the ELIXIR 3DBioInfo community (26), which aims to
further integrate annotations and bioinformatics data re-
lated to macromolecular structure and to act as a forum
for structural bioinformatics resources and research teams.
PDBe-KB partners have agreed resource governance guide-
lines (http://pdbe-kb.org/guidelines), whose key points are
summarised below: (i) the data contributed to PDBe-KB
is free from any restrictions on distribution and re-use; (ii)
the partners are responsible for the quality of the data they
contribute; (iii) protocols for data generation must be de-
scribed in peer-reviewed publications; and (iv) in case of
predicted/calculated annotations, the contributing partner
commits to submit data updates at least once a year, i.e.
to provide annotations for newer PDB entries and/or to
update the existing annotations when the underlying algo-
rithms change. Literature-based manually curated resources
may contribute data updates less frequently. PDBe-KB con-
venes annual general meetings where these guidelines are re-
viewed, new/prospective members present their work, and
the overall progress and plans are discussed. New areas of
future research are also identified with regards to gaps in
annotations, improved data visualization and benchmark-
ing of computational methods that provide annotations.
IMPLEMENTATION
The PDBe-KB infrastructure and workflow has two main
parts (Deposition and Access) and can be divided into five
components, described below and schematically depicted in
Figure 2: (i) the data exchange JSON schema; (ii) the data
deposition and validation system; (iii) the graph database
that stores the aggregated data; (iv) the API enabling inter-
nal and external data access and (v) the reusable web com-
ponents for data visualization.
Data deposition
To facilitate data transfer and enhance interoperability, the
consortium members have collaboratively designed a light-
weight data exchange schema, available at https://gitlab.ebi.
ac.uk/pdbe-kb/funpdbe/funpdbe-schema. The schema is a
JSON specification and it defines the mandatory and op-
tional fields required for deposition. The schema repre-
sents PDB entries hierarchically, with entry information
at the root, and chains, and residues on subsequent lev-
els. Residues may have multiple associated annotations,
grouped together in ‘sites’ or ‘residue groups’ which pro-
vide labels for residues that belong together. For example,
certain residues may together compose a druggable pocket
(7), where each residue would have its distinct associated
probability score, yet would be referenced to the same site,
labelled ‘pocket 1’.
It is mandatory to provide residue-level annotations us-
ing the PDB author residue identifiers (i.e. the residue num-
bering provided by the original authors of the PDB entry)
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Table 1. Partner resources contributing annotations to PDBe-KB
Partner resource (Reference) Resource leader Type of annotations Number of PDB entries
COSPI-Depth (21) M. S. Madhusudhan Residue depth 141 097
P2rank (6) D. Hoksza Binding site predictions 138 892
Arpeggio (15) T. Blundell Ligand interactions 117 023
3DComplex (14) E. D. Levy Interaction interfaces 111 555
DynaMine (19) W. Vranken Backbone flexibility predictions 98 548
POPSCOMP (20) F. Fraternali Solvent accessibility 77 578
AKID (11) M. Helmer-Citterich Kinase-target predictor 41 492
ChannelsDB (9) R. Svobodova Molecular channels 25 351
CATH-FunSites (13) C. Orengo Functional site predictions 23 975
canSAR (7) B. al-Lazikani Druggable pocket predictions 17 804
FoldX (17) L. Serrano Energetic consequences of mutations 3778
ProKinO (10) N. Kannan Curated regulatory sites 3673
14–3-3-Pred (12) G. Barton Binding site predictions 1941
CaMKinet (in preparation) M. Kumar Curated PTM sites 1076
M-CSA (5) J. Thornton Curated catalytic sites 919
3DLigandSite (8) M. Wass Binding site predictions 910
Missense3D (18) M. Sternberg Mutations in Human Proteome 0*
MetalPDB (16) A. Rosato Curated metal binding sites 0*
ELM (24) T. Gibson Short linear motifs 0*
PDBe-KB integrates data contributed by partner resources who provide a wide array of functional and biophysical annotations for PDB structures.
Transfer of annotations is in progress.
Figure 2. The infrastructure of PDBe-KB can be divided into data deposition and data access parts. Data deposition includes the data exchange format
specification, the private FTP areas for depositors and the internal validation and processing pipeline hosted by PDBe. The data is integrated in a dis-
tributable graph database, and 50 public API endpoints serve data from it. These endpoints power all the reusable PDBe-KB web components. These web
components are combined to create the aggregated views
to map annotations to residues. In case of predicted anno-
tations, the raw scores and confidence scores are also re-
quired. The depositors are encouraged to provide URLs
linking to the original, complete datasets of which the de-
posited annotations are often a subset, although in some
cases a generic URL to the resource or software can be
provided.
The schema is maintained by the PDBe team and is up-
dated according to the requirements of the consortium,
tracking the changes in a changelog file. The repository of
the schema also contains example JSON files that can serve
as templates for prospective collaborators.
Deposition of annotations to PDBe-KB starts with dis-
cussions between new partners and PDBe, and after agree-
ing to the PDBe-KB guidelines, the prospective contribu-
tors convert their data to the PDBe-KB data exchange for-
mat described above. To facilitate the data conversion, a
standalone Python package is provided to check if these files
comply with the schema specification, as well as to perform
all the consistency checks that the server-side deposition
pipeline would perform. The package is available at https:
//gitlab.ebi.ac.uk/pdbe-kb/funpdbe/funpdbe-validator.
After the annotations are converted to compliant JSON
files, they are transferred to private FTP areas provided
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by EMBL-EBI, and that serve as the authoritative sources
for the annotations. The PDBe team runs an internal high-
throughput validation and data processing pipeline weekly
to perform all the checks and post-processing necessary for
integrating the submitted annotations into the PDBe-KB
graph database, described in the next section.
Data access
One of the major advantages of building a knowledge base
such as PDBe-KB is the co-location and interconnected-
ness of diverse types of information in a single environ-
ment. To capitalise on this advantage, all the annotations
provided by PDBe-KB partners are integrated with the
core PDBe data in a graph database powered by Neo4j
(https://neo4j.com). Each PDB structure is represented as
a tree in this graph, with the root being the PDB entry, con-
nected to entities (unique molecules) and chains (instances
of these molecules). Entities and chains are connected to
residues. Where the mapping is available through the SIFTS
data (27), PDB residues are connected to the corresponding
residues in UniProtKB sequences. PDB residues (>150 mil-
lion) are also linked with all the available PDBe-KB anno-
tations, e.g. whether the given residue is part of a catalytic
site or belongs to a macromolecular interaction interface.
Integrating PDB and PDBe-KB data as a graph allows
the straightforward transfer of annotations from PDB en-
tries to both directly mapped and to highly similar (90%
identity) UniProtKB sequences and by extension to other
PDB entries connected to those UniProt accessions. Weekly
snapshots of the graph database index are made available
on the PDBe FTP area at ftp://ftp.ebi.ac.uk/pub/databases/
msd/graphdb/. The compressed snapshot required 102 Gb
of storage (∼500 Gb uncompressed) as of August 2019.
To ensure consistent and robust access to all the PDBe-
KB data stored in the graph database, the PDBe team
has developed a REST API (implemented in the Flask
framework for Python - https://palletsprojects.com/p/flask),
which contains 50 public endpoints. Detailed documenta-
tion and examples for each endpoint are available at https:
//pdbe-kb.org/api. This API powers the new PDBe-KB web
components and pages and is also used by PDBe entry
pages, PDBe query system, and has already been integrated
into some of the other EBI resources.
Web components
Clear and intuitive visualisation of structural data is cru-
cial for conveying scientific information to the diverse user
community. PDBe-KB presents the core PDB data and the
biological context annotations on novel aggregated views
for structural data. The first set of such views focus on
full-length proteins (UniProtKB accessions). These views
are assembled from modular, reusable and customisable
web components which retrieve the data via a REST API
(see above in the ‘Data access’ section). These components
are implemented in the Angular 6+ framework (https://
angular.io) and include textual and pictorial data represen-
tations and interactive visualizations. Specifically, to dis-
play PDBe-KB annotations we use the new version of the
ProtVista sequence feature viewer (28) (Figure 3A), which
is a visualization tool co-developed by UniProt (29), Inter-
Pro (30) and PDBe (25) (available at https://github.com/ebi-
webcomponents/nightingale) and, in order to display anno-
tations in 3D, we use the macromolecular viewer LiteMol
(31) (Figure 3B, available at https://www.ebi.ac.uk/pdbe/
pdb-component-library).
AGGREGATED VIEWS OF PROTEINS
To display the functional annotations and structural data
in a useful manner, we have developed a set of novel web
pages (aggregated views) that provide an overview of all the
structure data related to a full-length protein (UniProtKB
accession), as opposed to the conventional pages that fo-
cus on single PDB entries. These novel views were designed
following extensive gathering and analysis of user require-
ments and were launched in March 2019.
The aggregated views for proteins contain seven sections,
which aim to answer specific scientific questions: (i) sum-
mary: how many PDB entries map to the UniProtKB ac-
cession? How many ligands and macromolecular partners
are observed in the PDB interacting with the protein in
question? How many types of annotations and how many
publications are available? Which PDB entries contain rep-
resentative structures of the protein, and what do these
representative structures look like?; (ii) structural coverage
and domains: what PDB entries are available for a given
protein and their mapping onto to the UniProt sequence,
and what domains are present in these entries?; (iii) small
molecules: which small molecules are observed to either in-
teract directly with the protein in question or are observed
in PDB entries containing it?; (iv) macromolecular interac-
tions: which macromolecules does the protein interact with
according to the available data in PDB entries?; (v) func-
tional annotations: what are the annotations deposited by
PDBe-KB partner resources for the protein?; (vi) similar
proteins: For proteins with structures available in the PDB,
a list of similar proteins, with high sequence identity, from
UniProtKB without any structure data and if there are no
data in PDB for the protein of interest, are there proteins
with high sequence identity that have structural data avail-
able in the PDB? and (vii) publications: which are the pri-
mary publications citing the PDB entries related to the pro-
tein? What reviews are available either based on PDB or
UniProtKB accessions for this protein?
Summary and structural overview
The summary section provides an overview of all the avail-
able data using icons that also serve to navigate between the
various sections (Figure 4A). Basic information such as the
gene name, species and biological function of the protein
is provided by the Proteins API (32). Known enzymes and
proteins implicated in diseases are labelled accordingly. The
section also provides a gallery of representative structures
available for the various segments of the full-length protein.
These representative PDB structures are selected based on
sequence coverage, resolution and data quality (33). Struc-
tural studies of large proteins tend to yield multiple struc-
tures of shorter (often non-overlapping) segments of the pri-
mary sequence that are described in different PDB entries.
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Figure 3. The aggregated protein views are built using several web components, the main components being ProtVista and LiteMol. ProtVista (A) is a
sequence feature viewer co-developed by UniProt, PDBe and InterPro. It can be used to display residue-level information mapped to sequences. Our
implementation of LiteMol (B) is a lightweight molecular viewer wrapped into a reusable web component that allows the visualisation of biological
assemblies, complexes and ligand binding sites.
This section aims to simplify the navigation between the
various entries. Clicking on the images of any of the rep-
resentative PDB structures launches an instance of the in-
teractive 3D visualization tool LiteMol (31).
The Structures and Domains section provides an
overview of all (i.e. not just the representative) PDB entries
available for the protein and displays which region of the
protein these PDB entries cover (Figure 4B). It also indi-
cates which residues are modeled with atomic coordinates
(i.e. observed), and which ones are not (i.e. unobserved),
and allows identification of PDB entries containing partic-
ular domains from Pfam (34), CATH (35) and SCOP (36).
Additionally, it displays the secondary structure content of
the representative PDB chains and predictions of intrinsic
disorder provided by MobiDB (37). All this information
is displayed using an implementation of the ProtVista se-
quence feature viewer (28).
Galleries and annotations
The ligands and environments section displays a gallery of
all the unique small molecules that are observed to be in-
teracting with the protein of interest in any of the PDB en-
tries (Figure 5A), as well as any small molecules observed
in the same PDB entry as the protein of interest (i.e. not
necessarily interacting directly). This gallery can be filtered
using molecule names, three-letter molecule (chemical com-
pound) identifiers and PDB identifiers, and clicking on each
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Figure 4. The first two sections of the aggregated views of proteins provide an overview of all the data available in PDB for a protein of interest. The view
includes the number of interacting small-molecules, macromolecular interaction partners and functional annotations, as well as the number of publications
related to the PDBs, mapped to the protein (A). It also offers visual help for identifying all the PDB entries that cover various segments of the protein, as
well as showing representative non-overlapping structures both as static images and interactive 3D viewer (B).
image displays the ligand and its environment in 3D using
LiteMol (31). If the molecule acts as a cofactor (38), this is
also indicated in this section.
Below the gallery, ProtVista is used to highlight all the
residues of the protein that directly interact with each of
the small molecules, as determined by the Arpeggio tool
(15). Each row shows the residues interacting with a partic-
ular small molecule, while collapsing the category can pro-
vide an overview of all the binding sites, which can be used
to find protein sequence patterns in protein–ligand inter-
actions. This overview can thus help in differentiating be-
tween sporadic interaction sites of solvent molecules and
functionally relevant binding pockets.
The macromolecular interactions section has a similar
layout to the ligands and environments section and uses the
same web components to display different data (Figure 5B).
The gallery in this section shows all the macromolecular
partners which are directly interacting with the protein of
interest, in at least one of the PDB entries and highlights
how many PDB entries this interaction is observed. It also
provides links to the aggregated views for these partner pro-
teins. The images can be clicked to display the complexes in
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Figure 5. The aggregated protein views provide information on all the observed interactions between the protein of interest and ligands or macromolecular
interaction partners. The gallery of ligands (A) and macromolecules (B) can be used to display their interactions in an interactive LiteMol instance, and
to navigate to the corresponding PDBe and PDBe-KB entry pages to get more information about the partner molecules. Additionally, all the available
functional annotations and biophysical parameters provided by PDBe-KB partner resources are being displayed using ProtVista (C).
3D using LiteMol (31). Again, ProtVista is used to high-
light all the residues that are directly interacting with the
macromolecular partners, i.e. all the interaction interfaces
are identified and listed.
The subset of the annotations provided by PDBe-KB
partners are displayed in the additional annotations sec-
tion of the first version of the aggregated views for proteins
(Figure 5C). This section shows all the predicted and exper-
imentally determined functional sites and biophysical pa-
rameters contributed by the partner resources listed in Table
1. Curated annotations are colored blue, while prediction-
based annotations are colored grey, to allow clear visual
distinction between the two categories. Additionally, all the
available variation data from UniProt (29) are displayed.
All these annotations (as well as any data displayed with
ProtVista from any of the sections) can be downloaded in
CSV and JSON formats.
Similar proteins
The similar protein section shows all the UniProtKB acces-
sions that are in the same UniRef90 cluster as the protein of
interest, i.e. those proteins that share >90% sequence iden-
tity, further restricted to a minimum of 70% coverage by a
single PDB structure (27). Further developing this section
can help to transfer annotations and structural information
from approximately 47 500 structurally characterised pro-
teins (i.e. UniProtKB accessions represented in the PDB)
to more than 2.2 million UniProtKB accessions reached via
the UniRef90 clusters.
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Publications
The publication section provides links and summary infor-
mation of publications that are either: (i) the primary pub-
lications of PDB entries related to the protein of interest;
or (ii) reviews where these PDB entries are mentioned; or
(iii) reviews that are specifically related to the UniProtKB
accession of the protein of interest. These references can be
filtered by keywords and exported in CSV and BibTeX for-
mat.
CONCLUSIONS AND OUTLOOK
PDBe-KB is an open-access, collaborative and integrated
resource managed by the PDBe team at EMBL-EBI. The
goal of PDBe-KB is to place macromolecular structure data
in their biological context, and therefore to help the broader
scientific community to utilize these data in both funda-
mental and applied research and education, as well as to
reduce the fragmentation of the valuable annotation data
derived by many structural bioinformatics resources. PDBe-
KB was established in 2018, and since then it has gathered
contributions from 18 resources from 8 countries, provid-
ing over 520 million residue-level annotations. PDBe-KB
recently became an activity of the ELIXIR 3DBioInfo com-
munity, which aims to bring together structural bioinfor-
matics developers and scientists to work towards FAIRness
of structural annotations data (23).
PDBe-KB aims to provide novel aggregated views of
PDB data and their annotations, with the first set of such
aggregated views, launched in March 2019, focusing on full-
length proteins (i.e. UniProtKB accessions). We continue to
work on displaying additional functional and structural an-
notations contributed by the PDBe-KB partner resources
and by transferring annotations between proteins which are
in the same UniRef90 cluster.
Recently, we have started designing the next set of ag-
gregated views that will focus on small molecules in the
PDB and will integrate the structural data from the PDB
with the biological context annotations pertaining to small
molecules. These small-molecule-centric views are expected
to be released in the first half of 2020. Concurrently, in col-
laboration with the Complex Portal team (39) at EMBL-
EBI we have started investigating the data and visualization
requirements for creating aggregated views aimed at macro-
molecular complexes.
To further improve data accessibility, we packaged the
PDBe-KB graph database and made it distributable so that
the complete database can be installed and queried locally
by the scientific community and industry partners alike.
We extend an invitation to explore the possibility of join-
ing the PDBe-KB consortium to new partners who can
fill the gaps in current PDBe-KB biological context an-
notations, in particular pertaining to nucleic acids, mem-
brane proteins, peptides, antibodies and biophysical param-
eters derived from experimental characterization of small
molecule binding sites and protein complexes.
In conclusion, PDBe-KB brings structural data and an-
notations closer to the broader scientific community by al-
lowing convenient access to data that would have been oth-
erwise available in fragments from many specialist data re-
sources. PDBe-KB also serves as a platform that helps spe-
cialist data resources to increase their visibility and helps
them to increase the FAIRness of their data.
DATA AVAILABILITY
PDBe-KB is available at https://pdbe-kb.org and the pro-
tein aggregated views can be found at https://pdbe-kb.org/
proteins. The data exchange format is available at https://
gitlab.ebi.ac.uk/pdbe-kb/funpdbe/funpdbe-schema and the
JSON validator that can help depositors check their
data files can be found at https://gitlab.ebi.ac.uk/pdbe-
kb/funpdbe/funpdbe-validator. The Neo4J graph database
snapshots are available via FTP at ftp://ftp.ebi.ac.uk/pub/
databases/msd/graphdb/. Finally, the API with 50 pub-
lic API endpoints and their documentation is available at
https://pdbe-kb.org/api.
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